Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (50.0%)
N/A1 (50.0%)

Trials by Status

enrolling_by_invitation125%
completed250%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

18F-fluorocholine PET/CT for Hyperparathyroidism

NCT04316845
enrolling_by_invitationphase_3

Fluorocholine PET/CT Basket Trial

NCT04150458
unknown

18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

NCT03643055
completed

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

NCT02793882

Clinical Trials (4)

Showing 4 of 4 trials
NCT04316845Not Applicable

18F-fluorocholine PET/CT for Hyperparathyroidism

Completed
NCT04150458Phase 3

Fluorocholine PET/CT Basket Trial

Enrolling By Invitation
NCT03643055

18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

Unknown
NCT02793882

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4